Clinical Trial Update: Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC [Phase 2]

View source ↗

Summary

This is a Phase II neoadjuvant trial evaluating cetuximab in combination with cemiplimab for patients undergoing surgery for head and neck squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Cetuximab (cetuximab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING